The effect of topical corticosteroids on Ki67 and p53 expression in vulval lichen sclerosus

Summary Background Topical corticosteroids have become the treatment of choice for genital lichen sclerosus (LS) and are believed to be required for long‐term relief of symptoms. Objectives To compare vulval LS that had been treated with topical corticosteroids, vulval LS that had not received topic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of dermatology (1951) 2002-09, Vol.147 (3), p.503-508
Hauptverfasser:	Rolfe, K.J., Crow, J.C., Reid, W.M.N., Benjamin, E., MacLean, A.B., Perrett, C.W.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Topical Adolescent Adult Aged Aged, 80 and over Anti-Inflammatory Agents - pharmacology Child corticosteroids Female Glucocorticoids Humans Immunoenzyme Techniques immunohistochemistry Ki-67 Antigen - drug effects Ki-67 Antigen - metabolism Ki67 lichen sclerosus Lichen Sclerosus et Atrophicus - drug therapy Lichen Sclerosus et Atrophicus - metabolism Middle Aged p53 Tumor Suppressor Protein p53 - drug effects Tumor Suppressor Protein p53 - metabolism Vulva - metabolism Vulvar Diseases - drug therapy Vulvar Diseases - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!